Medical Oncology: Canine Rescue Lymphoma
What are the Rescue Protocols for Canine Lymphoma?
Most dogs with lymphoma treated with CHOP chemotherapy achieve a complete remission, meaning we can no longer detect cancer cells in their body. The duration of remission varies from a few months to a year or more after completion of treatment. Remission does not equal cure, and 95% of dogs have detectable disease at some point following chemotherapy. When this occurs, the dog is “out of remission” because their disease relapsed.
Some dogs achieve only a partial response to CHOP chemotherapy. This means their disease burden decreases, but never to the point where we cannot detect it. Alternatively, some dogs initially show a complete response, but their disease becomes detectable before finishing the 6-month course of treatment. The cancer cells of these partially/initially responding dogs have developed resistance to CHOP chemotherapy.
Relapse and resistance are devastating, but expected, consequences of having lymphoma. When they occur, we recommend treatment with “rescue” chemotherapy. Common rescue protocols are listed below. We will discuss the pros and cons of each protocol, as they relate to your dog and your goals, and assist you in choosing the best plan of action.
With rescue treatment, we aim for at least a durable partial remission. Therefore, the remission rates below include both partial and complete responses. Should you decide to pursue further chemotherapy, we will recheck lab work (complete blood count, serum chemistry panel, and urinalysis) to ensure your dog is a good candidate for treatment. Other diagnostics are recommended on a case by case basis.
FOR DOGS WITH RELAPSED LYMPHOMA
Restarting CHOP chemotherapy: If more than two months has elapsed between finishing CHOP and relapse, we recommend restarting CHOP treatment. This option has an 80% chance of inducing another durable complete remission. The duration of remission depends on the length of the first remission.
Side effects are the same as during the first CHOP protocol.
Note: If your dog received 6 doses of doxorubicin during their first CHOP protocol, due to concerns for cardiotoxicity, we will discuss substituting doxorubicin for another chemotherapy drug (mitoxantrone).
FOR DOGS WITH RELAPSED OR RESISTANT LYMPHOMA
L-asparaginase (L-spar)/CCNU (Lomustine):
L-asparaginase is given as a subcutaneous injection and CCNU is an oral drug. This combination is given every three weeks. There is an 80-90% chance of remission. Responses typically last about three treatments but could be longer. Should a complete remission be attained, we recommend a total of 6-8 treatments.
Side effects include temporary low white blood cell counts. Upset stomach signs like vomiting, diarrhea or poor appetite are rare. CCNU can cause liver damage and affect platelet counts, so lab work is monitored closely during treatment. Please note that L-asparaginase is given with the first 1-2 treatments only.
Estimated cost: $1,300-$1,400 total for first 2 treatments, $500 per treatment thereafter
This protocol involves administering two injectable chemotherapy drugs given at the same time (mustargen and vincristine), along with two oral medications given at home (prednisone and procarbazine). Dogs receive both injectable drugs on day 1 and again one week later. The oral drugs are given at home starting on day 1 and continued for 14 days. This 14-day period is called a cycle of MOPP. This cycle is followed by a week-long “rest” period and then repeated. There is a 65% chance of remission. Responses typically last about 2-3 cycles but could be longer. Should a complete remission be obtained, we recommend a total of 6-8 cycles.
Side effects are rare but include temporary upset stomach signs and temporary low white blood cell counts.
Estimated cost per cycle: $1,500
This is an injectable chemotherapy drug given once every three weeks. There is a 50-75% chance of remission, which usually lasts between 1-4 treatments, but can be longer. Should a complete remission be obtained, we recommend a total of five treatments.
Side effects include temporary upset stomach signs. Rare side effects include liver value elevation, skin changes and scarring of the lungs.
Estimated cost per treatment: $600-$700
This is an injectable form of chemotherapy given once every three weeks. The chance of remission is about 50%. Typical responses last for about 4 treatments. Should a complete remission be obtained, we recommend a total of 6 treatments.
Side effects include temporary upset stomach signs and/or low white blood cell counts.
Estimated cost per treatment: $350-$450
This is an intravenous chemotherapy treatment given as a long infusion over 5-6 hours every 2-3 weeks. The chance of remission is 35%. Typical responses last for 2-3 treatments. Should a complete remission be obtained, we recommend a total of 6 treatments.
Side effects include temporary upset stomach signs and/or low white blood cell counts and decreased platelet counts. In some cases, we recommend combining dacarbazine with other drugs (e.g. CCNU, doxorubicin, or mitoxantrone) to potentially increase efficacy.
Estimated cost per treatment: $500
L-asparaginase is administered as an injection under the skin and prednisone is given orally at home. This is a highly effective treatment, but dogs quickly develop resistance.
This option is the LEAST likely to cause any side effects beyond using prednisone alone. Treatments can be repeated every few weeks or as needed. Repeat use can lead to allergic reactions.
Estimated cost per treatment: $300
This is a ‘palliative’ protocol where you administer prednisone at home. Prednisone can be an anti-cancer treatment for some dogs with lymphoma and can also be a drug that helps them feel better while maintaining their appetite and energy. The benefit doesn’t typically last more than a few weeks to months once a dog is out of remission. Please note that prednisone is frequently prescribed in conjunction with the protocols listed above.
Estimated cost per month: $20-$30
The aforementioned options are not mutually exclusive and many patients receive multiple protocols as long as they continue to feel well.